Magdi E. A. Zaki
Orcid: 0000-0002-5643-9202
According to our database1,
Magdi E. A. Zaki
authored at least 7 papers
between 2024 and 2025.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2025
Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations.
Comput. Biol. Medicine, 2025
Targeting PARP14: An in silico framework for identifying novel Competitive inhibitors via 3D-QSAR pharmacophore modeling and molecular dynamics.
Comput. Biol. Medicine, 2025
Identification of Therapeutic Compounds Targeting Phosphatidylinositol 3-Kinase (PI3K) Through Molecular Docking, Dynamics Simulation, and DFT Calculations.
Comput. Biol. Chem., 2025
e-QSAR (Explainable AI-QSAR), molecular docking, and ADMET analysis of structurally diverse GSK3-beta modulators to identify concealed modulatory features vindicated by X-ray.
Comput. Biol. Chem., 2025
Computationally guided design and synthesis of pyrimidine-oxazole hybrids as novel antidiabetic agents: kinetic and molecular interaction studies.
Comput. Biol. Chem., 2025
2024
Discovery of novel MLK4 inhibitors against colorectal cancer through computational approaches.
Comput. Biol. Medicine, 2024
Unveiling potential repurposed drug candidates for Plasmodium falciparum through in silico evaluation: A synergy of structure-based approaches, structure prediction, and molecular dynamics simulations.
Comput. Biol. Chem., 2024